SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Bill Wexler's Profits of DOOM -- Ignore unavailable to you. Want to Upgrade?


To: mesaone who wrote (2809)9/16/1998 9:38:00 PM
From: Mama Bear  Respond to of 4634
 
PSO for BTIM is off the scale.

Barb



To: mesaone who wrote (2809)9/16/1998 10:04:00 PM
From: Bill Wexler  Read Replies (5) | Respond to of 4634
 
<<the shorts drove this price down because they were able to short it without actually borrowing the stock (naked shorting),>>

You are reaffirming my belief that you do not have a clue about the stock market. I think you have been reading too many paranoid fantasies on the RMIL, MTEI and TokyoMex threads.

<<Biotime's fundamentals are not in question.>>

You're right, because there are no "fundamentals". Biotime is a speculative biotech play - and a poor one at that.

<<I would be surprised if you are not actually accumulating it now>>

Surprise! I'm not.

<<I don't like you Bill Wexler.>>

Oh darn, I guess I'm going to have to cross you off my Christmas card list.

<<I think that you are an arrogant s.o.b.>>

I'm also handsome...and oh yeah...rich.

<<and I am looking forward to ... does the term, EAT CROW mean anything to you.>>

It's interesting how investors in scam stocks think that people such as myself and Mr. pink are their "enemies". Your real enemy is your own ego. The reason I make money in the stock market and people such as yourself keep losing it is because you place your investment in the context of a battle between shorts and longs. Instead of cutting losses and investing in higher quality companies, you spend hours writing scathing attacks on the internet and ramble endlessly about short-squeezes, naked shorts, SEC investigations into shorts sellers, etc. etc. etc.

I recently took a very large long position in Costco. I did not bother to check the short position nor do I care. I bought it because its a great, growing business. I shorted Biotime because the stock was artificially inflated on hype and absurd projections.

<<we don't like each other.. so maybe we should just stop conversing.
my final words ... i know YOU are accumulating.. so don't BS this board.>>

Jesus, you're an idiot.



To: mesaone who wrote (2809)9/16/1998 11:41:00 PM
From: BDR  Read Replies (1) | Respond to of 4634
 
I visited your website and read the piece by Voelker. Evidently the future of Hextend is based on the following:

<<< And Hextend's Phase 3 human clinical trials[2] showed a statistically important drop of 4 to 1 in coagulation related adverse events, when compared to generic hetastarch in normal saline.>>>

Without knowing the denominator I can't comment on the clinical significance of this finding. However, as a surgeon, while volume expanders are useful, a company based on this product alone will not fulfill the promise of this statement:

<<this company is gonna blow biotechs out of the water...soon enough>>

You did, however, state that:

<<Hextend is their their entry to being legit (fda approval) but... it is the other products which will really drive this company.>>

I haven't thoroughly reviewed your site but I did not see a mention of the other products. May I ask what they are?



To: mesaone who wrote (2809)9/16/1998 11:56:00 PM
From: Druss  Read Replies (2) | Respond to of 4634
 
Mesaone--The way I have seen 'naked short' used is as a short position without a call behind it. So the short is risking the possibility of a runup. Shorting without borrowing is called illegal. Any evidence you have that this occurred should be sent to the SEC. No evidence that this occurred while spouting about how it did is called destroying your credibility.
Druss